Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
Chiadi E Ndumele, Ian J. Neeland, Katherine R. Tuttle, et al.
Circulation (2023) Vol. 148, Iss. 20, pp. 1636-1664
Open Access | Times Cited: 193

Showing 1-25 of 193 citing articles:

Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
Chiadi E Ndumele, Janani Rangaswami, Sheryl L. Chow, et al.
Circulation (2023) Vol. 148, Iss. 20, pp. 1606-1635
Open Access | Times Cited: 322
Development and Validation of the American Heart Association’s PREVENT Equations
Sadiya S. Khan, Kunihiro Matsushita, Yingying Sang, et al.
Circulation (2023) Vol. 149, Iss. 6, pp. 430-449
Closed Access | Times Cited: 191
Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association
Sadiya S. Khan, Josef Coresh, Michael Pencina, et al.
Circulation (2023) Vol. 148, Iss. 24, pp. 1982-2004
Closed Access | Times Cited: 167
Cardiovascular-Kidney-Metabolic (CKM) syndrome: A state-of-the-art review
Sneha Annie Sebastian, Inderbir Padda, Gurpreet Johal
Current Problems in Cardiology (2023) Vol. 49, Iss. 2, pp. 102344-102344
Closed Access | Times Cited: 49
Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050—Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association
Karen E. Joynt Maddox, Mitchell S.V. Elkind, Hugo J. Aparicio, et al.
Circulation (2024) Vol. 150, Iss. 4
Closed Access | Times Cited: 46
Metabolic syndrome
Ian J. Neeland, Soo Lim, André Tchernof, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 32
The major global burden of chronic kidney disease
Michel Jadoul, Mabel Aoun, Mannix Masimango Imani
The Lancet Global Health (2024) Vol. 12, Iss. 3, pp. e342-e343
Open Access | Times Cited: 30
Diabetes mellitus—Progress and opportunities in the evolving epidemic
E. Dale Abel, Anna L. Gloyn, Carmella Evans‐Molina, et al.
Cell (2024) Vol. 187, Iss. 15, pp. 3789-3820
Closed Access | Times Cited: 27
The impact of population ageing on the burden of chronic kidney disease
Nicholas C. Chesnaye, Alberto Órtiz, Carmine Zoccali, et al.
Nature Reviews Nephrology (2024) Vol. 20, Iss. 9, pp. 569-585
Closed Access | Times Cited: 23
The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better
Omar Mhaimeed, Zain Burney, Stacey L. Schott, et al.
American Journal of Preventive Cardiology (2024) Vol. 18, pp. 100649-100649
Open Access | Times Cited: 20
Projected Changes in Statin and Antihypertensive Therapy Eligibility With the AHA PREVENT Cardiovascular Risk Equations
James A. Diao, Ivy Shi, Venkatesh L. Murthy, et al.
JAMA (2024) Vol. 332, Iss. 12, pp. 989-989
Closed Access | Times Cited: 20
Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0–3: a nationwide prospective cohort study
Weipeng Li, Chaonan Shen, Weiya Kong, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18
GLP-1 receptor agonists’ impact on cardio-renal outcomes and mortality in T2D with acute kidney disease
Heng‐Chih Pan, Jui‐Yi Chen, Hsing‐Yu Chen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
Sankar D. Navaneethan, Nisha Bansal, Kerri L. Cavanaugh, et al.
American Journal of Kidney Diseases (2024)
Closed Access | Times Cited: 16
Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States
Abdul Mannan Khan Minhas, Roy O. Mathew, Laurence S. Sperling, et al.
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 18, pp. 1824-1826
Closed Access | Times Cited: 14
Integrated Management of Cardiovascular–Renal–Hepatic–Metabolic Syndrome: Expanding Roles of SGLT2is, GLP-1RAs, and GIP/GLP-1-RAs
Nikolaos Theodorakis, Maria Nikolaou
Biomedicines (2025) Vol. 13, Iss. 1, pp. 135-135
Open Access | Times Cited: 5
Joint association of the inflammatory marker and cardiovascular-kidney-metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective study
Yifei Cao, Wenfeng Wang, Sining Xie, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 2
From Cardiovascular-Kidney-Metabolic Syndrome to Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Proposing an Expanded Framework
Nikolaos Theodorakis, Maria Nikolaou
Biomolecules (2025) Vol. 15, Iss. 2, pp. 213-213
Open Access | Times Cited: 2
Atherosclerosis and the Bidirectional Relationship Between Cancer and Cardiovascular Disease: From Bench to Bedside, Part 2 Management
Giuseppina Gallucci, Mario Larocca, Alessandro Navazio, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 334-334
Open Access | Times Cited: 1
Golgi protein 73: charting new territories in diagnosing significant fibrosis in MASLD: a prospective cross-sectional study
Shan Hong, Ziyu Liu, Ping Li, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access | Times Cited: 1
Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: a nationwide prospective cohort study
Gaoshu Zheng, Jian Jin, Fei Wang, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Inverse Relationship Between Serum Carotenoid Levels and Cardiovascular‐Kidney‐Metabolic Syndrome Among the General Adult Population
Mengli Chen, Shuyue Cai, Qinfeng Jia, et al.
Journal of Diabetes (2025) Vol. 17, Iss. 2
Open Access | Times Cited: 1
Atherogenic index of plasma and cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stage 1 to 3: a longitudinal study
Yu Zhang, Yue Song, Yinfei Lu, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access | Times Cited: 1
In memoriam: A tribute to Dr Scott M. Grundy
Neil J. Stone, Roger S. Blumenthal, W. Virgil Brown, et al.
Journal of clinical lipidology (2025)
Closed Access | Times Cited: 1
Impact of Multimorbidity on Mortality in Heart Failure With Mildly Reduced and Preserved Ejection Fraction
Mingming Yang, Toru Kondo, Pooja Dewan, et al.
Circulation Heart Failure (2025)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top